Ohio River Regional - AACE 19th Annual Meeting

Columbus, OH US
July 28, 2017 to July 29, 2017

Endocrinologists have one of the most diverse patient populations of any medical specialty. The plethora of endocrine conditions they see, and the dynamic pace of clinical research in those areas, requires that these professionals regularly update their knowledge of the varied conditions they treat.

This two-day meeting of the Ohio River Regional Chapter of the American Association of Clinical Endocrinologists is designed to do just that. Covering a wide variety of topics, including diabetes, neuroendocrine cancers, obesity, endocrine-related adverse effects of new cancer immunotherapies, menopause, osteoporosis, and Cushing’s disease, offers an educational smorgasbord designed to increase clinical knowledge and, thus, improve the quality of patient care and outcomes. This meeting will also feature a more personal presentation from a physician about the changes he has seen in his more than 50 years in the field of endocrinology.

This meeting builds off the success of the 2016 educational forum, in which nearly 90% of participants said they planned to make changes and/or reinforcements to their practice as a result of the information presented.

Target Audience

Endocrinologists, endocrine surgeons, and other health care professionals living in Indiana, Kentucky, Ohio and Pennsylvania who practice, or are interested in, the treatment of endocrine disease states. 

Learning Objectives

  1. List several common cutaneous complications associated with diabetes
  2. Discuss differential diagnoses of some skin disorders which afflict patients with diabetes
  3. Discuss management of common skin diseases in diabetic patients
  4. Recognize the impact of attending a diabetes camp on HbA1c in children with type 1 diabetes
  5. Recognize ghrelin is not related to hunger or energy consumed at breakfast in lean and obese women
  6. Understand panostotic fibrous dysplasia leads to progressive skeletal deformity and high bone turnover, predisposing to numerous fractures, and may be complicated by hypophosphatemia due to renal phosphate wasting
  7. After participating in a pre-meeting assessment tool, attendees will be able to recognize areas of potential shortcoming and strive to improve knowledge and consequential healthcare practices.
  8. Understand pathophysiology of obesity as a chronic disease
  9. Develop a practical working knowledge of obesity pharmacotherapy, and the utilization of weight loss medications in the context of comprehensive care
  10. Understand how to apply the AACE obesity clinical practice guidelines in real-world care of patients with obesity
  11. Identify the most common endocrine-related adverse effects of immune checkpoint inhibitors
  12. Review the clinical presentation and management of hypophysitis
  13. Review the clinical presentation of immune-therapy induced thyroid dysfunction
  14. Understand the AACE ASCVD Risk categories, identity the new "extreme risk” category, review the evidence of support and the LDL treatment goals
  15. Review the Risk Calculators identified in the Guidelines
  16. Review other aspects of the 2017 AACE Lipid Guidelines
  17. Discuss menopausal hormone and non-hormonal therapies
  18. Define GSM and FIASD and first in class therapies
  19. Detail benefits and risks of ET vs EPT therapies
  20. List some advances in managing diabetes in the past several years
  21. Relate microvascular benefits with better glucoregulation
  22. Appreciate and relate the role of technology in advancing Endocrinology
  23. Recognize the potential use of newer drugs for osteoporosis
  24. Comprehend the rationale for the new GIOP Guideline
  25. Approach the management in the difficult GIOP patient
  26. Understand Recent Advances in Diagnostics of Neuroendocrine Tumors
  27. Understand recent advances in Therapeutics of Neuroendocrine Tumors
  28. Understand benefits/risks of therapeutics
  29. Identify current diabetes apps and their benefits
  30. Explain to patients how to use apps to improve carb counting skills
  31. Explain to patients how to use apps to track glucose and insulin doses
  32. List 3 medications effective in the treatment of Cushing's disease
  33. List 3 adverse effects of mifepristone treatment
  34. Describe differences on glucose metabolism of the two approved treatments for Cushing's disease
  35. At the conclusion of the meeting, attendees will be able to measure learning that occurred that will enable the use of new healthcare techniques and practices and to review or confirm existing care modalities.
Additional information
Available for MOC Points?: 
No
Practice Area: 
Diabetes
Hypoglycemia
Obesity
General Endo
Course summary
Available credit: 
  • 10.00 AMA
  • 10.00 Attendance
Course opens: 
07/28/2017
Course expires: 
07/29/2018
Event starts: 
07/28/2017 - 6:00pm
Event ends: 
07/29/2017 - 5:15pm
Cost:
$0.00

FRIDAY, JULY 28, 2017

6:00 -7:00pm          Diabetes & Dermatology, Alok Vij, MD, FAAD

7:00 - 7:15pm         Break/Buffet Dinner

7:15 - 7:30pm         Business Meeting

7:30 - 8:30pm         Oral Abstract Presentations

                                 7:30 - 7:50pm - Abstract 1

                                 7:50 - 8:10pm - Abstract 2

                                 8:10 - 8:30pm - Abstract 3                               

8:30 - 9:15 pm        Welcome Reception 

SATURDAY, JULY 29, 2017

7:00 - 7:45am         Registration & Breakfast 

7:45 - 8:15am         Welcome & Pre Meeting Assessment

8:15 - 8:55am         Pharmacology of Obesity, Tim Garvey, MD, FACE

8:55 - 9:05 am        Q & A

9:05 - 9:45 am        Endocrine Effects of Anti-Tumor Immunotherapy Agents, Mabel Ryder, MD

9:45 - 9:55am         Q & A

9:55 - 10:30am       Break

10:30 - 11:10am     AACE Lipid Guidelines, Paul Jellinger, MD, MACE

11:10 - 11:20am     Q & A

11:20 - 12:00pm    Menopause and Hormone Therapy, Holly L. Thacker, MD, FACP, CCD, NCMP

12:00 - 12:10pm    Q & A

12:10 - 1:10pm      Lunch 

12:20 - 1:00pm      My Journey in Endocrinology, Sam Cataland, MD

1:10 - 1:50pm        Osteoporosis: A Tale of 3 Task Forces! Robert A. Adler, MD

1:50 - 2:00pm        Q & A

2:00 - 2:40pm        Recent Advances in Neuroendocrine Tumors: Diagnositics and Therapeutics, Manisha Shah, MD

2:40 - 2:50 pm       Q & A

2:50 - 3:20pm        Break

3:20 - 4:00pm        Management of Cushing`s Disease in the Patient Who Has Failed Surgery, Mark E. Molitch, MD, FACP

4:00 - 4:10pm        Q & A

4:10 - 4:50pm        The Practical Application of Diabetes Technology: From pumps, CGMs to app, Elizabeth Snyder, RD, LD, CDE

4:50 - 5:00pm        Q & A

5:00 - 5:15pm        Post Meeting Assessment 

5:15pm                  Adjourn 

Blackwell Inn at OSU Campus
2110 Tuttle Park Place
Columbus, OH 43210
United States

Robert A. Adler, MD

Chief, Endocrinology and Metabolism

McGuire Veterans Affairs Medical Center

Professor of Internal Medicine and of Epidemiology

Virginia Commonwealth University School of Medicine

Richmond, VA

Sammuel Cataland, MD

Professor Emeritus

The Ohio State University

Columbus, OH

Nivine Elhor, MS4

Wright State University

Boonshoft School of Medicine

Dayton, OH

W. Timothy Garvey, MD, FACE

Professor and Chair, Department of Nutrition Sciences

University of Alabama at Birmingham

Director, UAB Diabetes Research Center

Birmingham, AL

Paul S. Jellinger, MD, MACE

Professor of Clinical Medicine

University of Miami

Miller School of Medicine

Miami, FL

The Center for Diabetes & Endocrine Care

Fort Lauderdale, FL

Mark E. Molitch, MD, FACP

Martha Leland Sherwin Professor of Endocrinology

Division of Endocrinology, Metabolism and Molecular Medicine

Northwestern University Feinberg School of Medicine

Chicago, IL

Rachel Morgan, MD

Endocrinology Fellow

Indiana University School of Medicine

Indianapolis, IN

Mabel Ryder, MD

Assistant Attending

Division of Endocrinology and Division of Oncology

Mayo Clinic

Rochester, MN

Manisha Shah, MD

Professor of Internal Medicine, Ohio State University

Columbus, OH

Elizabeth Snyder, RD, LD, CDE

Diabetes Outreach Coordinator

Wexner Medical Center at The Ohio State University

Division of Endocrinology, Diabetes & Metabolism

Columbus, OH

Holly L. Thacker, MD, FACP, CCD, NCMP

Professor and Director Center for Specialized Women's Health

Cleveland Clinic Foundation

Executive Director, Speaking of Women's Health

Cleveland, OH

Alok Vij, MD, FAAD

Staff Dermatologist

Cleveland Clinic Foundation

Cleveland, OH

The American Association of Clinical Endocrinologists (AACE) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The American Association of Clinical Endocrinologists (AACE) designates this live activity for a maximum of 10.00 AMA PRA Category 1 Credit(s)™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Available Credit

  • 10.00 AMA
  • 10.00 Attendance

Accreditation Period

Course opens: 
07/28/2017
Course expires: 
07/29/2018

Price

Cost:
$0.00
Please login or register to take this course.